Medicare Enrolled

Dr. Scott Brook, M.D.

Hematology & Oncology · Palm Springs, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1180 N INDIAN CANYON DR, Palm Springs, CA 92262
7604164721
In practice since 2007 (18 years)
NPI: 1245424365 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brook from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brook? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brook

Dr. Scott Brook is a hematology & oncology specialist in Palm Springs, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Brook performed 826 Medicare services across 316 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brook received a total of $3,579 from 38 pharmaceutical and/or device companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brook is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 826 Medicare services $3,579 industry payments

Medicare Practice Summary

Medicare Utilization ↗
826
Medicare services
Bottom 46% in CA for hematology & oncology
316
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~46 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 625 $74 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 169 $51 $150
New patient office visit, complex (60-74 min) 32 $146 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,579
Total received (2018-2024)
Avg $511/year across 7 years
Top 49% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
190
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,466 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$113 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,048
2023
$368
2022
$231
2021
$99
2020
$104
2019
$762
2018
$966

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$118
Janssen Biotech, Inc.
$113
ABBVIE INC.
$70
Celgene Corporation
$67
Karyopharm Therapeutics Inc.
$66
Gilead Sciences, Inc.
$65
PFIZER INC.
$61
Novartis Pharmaceuticals Corporation
$60
Rigel Pharmaceuticals, Inc.
$59
ARRAY BIOPHARMA INC
$56
AstraZeneca Pharmaceuticals LP
$52
E.R. Squibb & Sons, L.L.C.
$39
SOBI, INC
$38
INTUITIVE SURGICAL, INC.
$35
BeiGene USA, Inc.
$28
Lilly USA, LLC
$21
Deciphera Pharmaceuticals Inc.
$19
Blueprint Medicines Corporation
$19
Agios Pharmaceuticals, Inc.
$17
GENZYME CORPORATION
$16
Kite Pharma, Inc.
$15
EMD Serono, Inc.
$15
Top 3 companies account for 28.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$829
Amgen Inc.
$337
AstraZeneca Pharmaceuticals LP
$263
Celgene Corporation
$166
Eisai Inc.
$164
GENZYME CORPORATION
$157
Janssen Biotech, Inc.
$143
Merck Sharp & Dohme Corporation
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
PFIZER INC.
$98
MENARINI SILICON BIOSYSTEMS, INC.
$96
Karyopharm Therapeutics Inc.
$86
Janssen Products, LP
$85
Rigel Pharmaceuticals, Inc.
$82
Novartis Pharmaceuticals Corporation
$81
ARRAY BIOPHARMA INC
$76
ABBVIE INC.
$70
SOBI, INC
$69
Gilead Sciences, Inc.
$65
Pharmacyclics LLC, an AbbVie Company
$46
Foundation Medicine, Inc.
$46
EMD Serono, Inc.
$44
EUSA Pharma (US) LLC
$42
Blueprint Medicines Corporation
$41
Lilly USA, LLC
$37
INTUITIVE SURGICAL, INC.
$35
Sobi, Inc
$30
BeiGene USA, Inc.
$28
Janssen Pharmaceuticals, Inc
$21
Deciphera Pharmaceuticals Inc.
$19
Agios Pharmaceuticals, Inc.
$17
Genentech USA, Inc.
$16
Monteris Medical Corporation
$16
Seagen Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Kite Pharma, Inc.
$15
Dova Pharmaceuticals
$11
Array BioPharma Inc.
$11
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CALQUENCE · CARVYKTI · CHANTIX · Cellsearch · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · FOUNDATIONONE · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · JADENU · JAYPIRCA · KANJINTI · KEYTRUDA · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · MEKINIST · Neuroblate · Nexavar · Nplate · OPDIVO · PADCEV · PLUVICTO · PYRUKYND · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Rezlidhia · SARCLISA · Sylvant · Trodelvy · VENCLEXTA · XARELTO · XPOVIO · Yescarta · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Palm Springs?
Compare hematology & oncology specialists in the Palm Springs area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
17
Per 100K population
0.7
County median income
$89,672
Nearest hospital
DESERT REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brook is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brook experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Brook performed 625 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brook receive payments from pharmaceutical companies?
Yes. Dr. Brook received a total of $3,579 from 38 companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brook's costs compare to other hematology & oncology specialists in Palm Springs?
Dr. Brook's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brook) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Palm Springs
Browse hematology & oncology specialists in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →